A Cross-Sectional Study on Oral Anticoagulant Utilization and Adverse Drug Reactions at Teaching Hospital, Iran
Shima Jafari, Sara Farooghi, Mandana Moradi · 2026
Read A Cross-Sectional Study on Oral Anticoagulant Utilization and Adverse Drug Reactions at Teaching Hospital, Iran by Shima Jafari, Sara Farooghi, Mandana Moradi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13225941.txt.
Description
Shima Jafari, Sara Farooghi, and Mandana Moradi report a 2026 study of blood thinning pills at a teaching hospital in Iran. These pills prevent clots, but wrong doses can cause harm and cut the benefit. The team checked how the pills were used and what side effects arose.
Records from April 2020 to September 2022 covered 1,027 adults on one of three pills. The most used pill was rivaroxaban, then warfarin, then apixaban. Warfarin served mainly for valve disease, while the newer pills served for rhythm faults and vein clots. Side effects hit about 12 percent of patients, mostly minor bleeding, and warfarin made up most of those cases. Guideline fit dosing was reached in about three fifths of cases.
Catalog record
| CREATOR | Shima Jafari, Sara Farooghi, Mandana Moradi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |